Balyasny Asset Management »

BioMarin Pharmaceutical shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $29M 462k 62.26
2012-12-31 $1.5M 31k 49.19
2012-06-30 $2.6M 65k 39.59
2011-09-30 $12M 365k 31.87
2011-06-30 $8.6M 315k 27.21

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical